NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/25/2026
Back to search
Official data from USPTO
EVER PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
06/25/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
10/22/2014
Registration date
03/08/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2026
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Unterach am Attersee, AT
Examiner
HUSSAIN, TASNEEM
Current location
Historical data usage
Mark description
The mark consists of the stylized and stacked wording "EVER PHARMA" with "EVER" in red and "PHARMA" in gray to the right of an off-center white star in a rounded red square. The background is white.
Holders and representatives
Holders
EVER Neuro Pharma GmbH
EVER Neuro Pharma GmbH
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations used for the treatment of central nervous system diseases and neurodegenerative diseases ; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption
Class 10
apparatus and instruments for medical use for the treatment of Parkinson disease; suture materials
Publications
History of USPTO decisions and trademark events.
51 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/25/2026
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/23/2026
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/23/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2026
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/04/2026
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/30/2026
ES71
TEAS SECTION 71 RECEIVED
02/24/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/08/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/09/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/04/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/25/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/24/2023
INPC
INVALIDATION PROCESSED
05/24/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/16/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/16/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
08/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2022
ES71
TEAS SECTION 71 RECEIVED
03/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/01/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/08/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/02/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/14/2016
FIMP
FINAL DISPOSITION PROCESSED
06/14/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/15/2016
PUBO
PUBLISHED FOR OPPOSITION
12/22/2015
GPNX
NOTIFICATION PROCESSED BY IB
12/18/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/02/2015
NPUB
NOTICE OF PUBLICATION
12/02/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2015
NREV
NOTICE OF REVIVAL - MAILED
11/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2015
PETG
PETITION TO REVIVE-GRANTED
11/11/2015
PROA
TEAS PETITION TO REVIVE RECEIVED
11/11/2015
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
09/11/2015
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/11/2015
RFNT
REFUSAL PROCESSED BY IB
03/06/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/13/2015
RFRR
REFUSAL PROCESSED BY MPU
02/13/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2015
CNRT
NON-FINAL ACTION WRITTEN
02/11/2015
DOCK
ASSIGNED TO EXAMINER
02/11/2015
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/29/2015
Continuous trademark protection
Get notified about every new filing that threatens EVER PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.